Skip to content
खोजि गर्नुहोस्...
Singhadarbar Logo
२०८१, १४ चैत्र बिहीबार
Shikhar Insurance
National Life

British pharmaceutical company to invest $2.5 billion in Beijing

सिंहदरबार संवाददाता

Hyundai
NCELL
NIMB

Agency. British pharmaceutical company AstraZeneca has signed a historic agreement to invest $2.5 billion in Beijing over the next 5 years.

Under the agreement, AstraZeneca will establish a global strategic research and development center in Beijing.

Which is the sixth globally and the second in China. AstraZeneca CEO Pascal Soriot said the investment highlights the multinational company’s confidence in Beijing’s world-class life sciences innovation ecosystem.

The pharmaceutical titan will also form a new joint venture in Beijing to develop, manufacture and commercialize innovative medicines targeting respiratory and other infectious diseases.

 

GBIME

प्रतिक्रिया दिनुहोस्

Top 5

1
2
3
4
5

सम्बन्धित् समाचार

post-thumb
post-thumb
post-thumb
post-thumb
post-thumb
post-thumb

Recent

post-thumb
post-thumb
post-thumb
post-thumb
post-thumb
post-thumb

Thoughts MORE

“25,000 people have found employment in IME Group, we are also working to create self-employment,” says Chairman Dhakal.

‘It is important to have a harmonious relationship between employers and workers’ – Chairman Dhakal

‘I am finding that the culture of paying off debt is slowly disappearing’, interview with Upendra Paudyal

‘Bank CEOs are confused about whether to give money if someone comes asking for it’ Interview with Dr. Ramesh Poudel

Chandra Dhakal’s view: ‘The residents of Phungling will get crores of rupees in investment and 300 jobs in the cable car’

‘Just because you are a little below par shouldn’t put you on the blacklist, bankers should also provide counseling’ – Governor Adhikari’s opinion